Traumatic Brain Injury Assessment & Management Devices Market Growth & Trends

The global traumatic brain injury assessment and management devices market size is anticipated to reach USD 4.7 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.3% over the forecast period. Increasing incidence of traumatic brain injuries (TBIs) and rising awareness about TBIs are driving the market growth. TBIs are a serious public health problem and each year it contribute a significant number of cases globally.

TBIs can be categorized as mild (concussion) and severe depending upon the condition of the patient and symptoms associated with the incident. Falls are leading cause of hospitalization in patients with TBI followed by motor vehicle accidents. As per the Centers for Disease Control and Prevention (CDC), at present, around 3.5 million people in U.S. have a permanent TBI-related disability. This is anticipated to boost the market growth over the forecast period.

Moreover, high demand for minimally invasive devices as they maintain cerebral blood flow and oxygen delivery, optimize intracranial pressure, minimize cerebral edema, and provide a healthy metabolic environment with minimal pain, efficacy, safety, and speedy recovery, is expected to boost the market growth. Several awareness campaigns, introduction of new products, and incorporation of advanced technologies by market players are likely to dive the market further. For instance, BioDirection launched ’NanoDx System’, which is a rapid Point-of-Care (PoC) test that can precisely confirm concussion/TBI in less than 2 minutes.

Traumatic Brain Injury Assessment & Management Devices Market Report Highlights

  • The imaging devices segment led the overall market with a share of 54.2% in 2019. The segment will retain the leading position in coming years on account of wide usage of these equipment in identifying patients with TBIs
  • The ICP monitoring segment held the maximum market share of 54.8% in 2019 and will expand further at a steady CAGR from 2020 to 2027 as this method is considered as a gold standard for the measurement of accurate ICP in patients with severe brain injury
  • Hospitals is estimated to be the largest end-use segment due to increasing number of complicated brain surgery procedures performed at hospitals as these healthcare facilities are equipped with high-quality and advanced devices
  • North America was the dominant regional market in 2019 and will maintain its position owing to availability of the latest treatment procedures and well-established healthcare facilities in the region